T cells in Group A Streptococcus infection: protection or pathology?
Liya Mathew, Mohammad Ali, Hermaleigh Townsley, Alice Halliday, Paul Klenerman, Thushan I. de Silva, Anu Goenka · 2026
Read T cells in Group A Streptococcus infection: protection or pathology? by Liya Mathew, Mohammad Ali, Hermaleigh Townsley, Alice Halliday, Paul Klenerman, Thushan I. de Silva, Anu Goenka (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13628493.txt.
Description
Mathew and colleagues published in twenty twenty-six a review of T cells in group A Streptococcus infection, asking whether they protect or harm. The bacterium, also called Streptococcus pyogenes, is a priority target for vaccine development. Vaccine work has stalled partly because protective immunity is poorly understood. Most effort has chased antibody markers of protection. The authors argue T cells may contribute far more than credited. Age patterns of T-cell reactivity mirror age patterns of disease.
T cells are also targets of the bacterium's superantigen toxins. Some T-cell types appear to protect against this and similar bacteria. Others, notably certain killer T cells, seem to drive tissue damage. The review weighs risk factors across epidemiology and clinical disease. It maps where T-cell research could unlock vaccine design. Harnessing the protective side while avoiding harm is the goal.
Catalog record
| CREATOR | Liya Mathew, Mohammad Ali, Hermaleigh Townsley, Alice Halliday, Paul Klenerman, Thushan I. de Silva, Anu Goenka |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |